Invests in
Locations:
Min Investment:
$10,000,000.00Max Investment:
$25,000,000.00Target Investment:
$17,500,000.00
Skills
Education
- Uo
- PU
- Uo
- W&
Lists including John
Work Experience
2013
Senior Advisor
2013
Advise on corporate, commercial, public policy and regulatory matters for life sciences and healthcare industry clients of this leading global law firm
2018
Venture Partner
2018
Growth and venture stage investments in innovative medtech companies
2013
Contributor
2013
Affiliate Professor
2012
Also occasional guest lecturer at the UW Foster School of Business
Guest Lecturer
1997
Lecturer in The Business of Biology, an interdisciplinary graduate course
Visiting Scholar and Guest Lecturer
2018
Dep't of Health Policy & Management, UCLA Seminar on Pharmaceutical Policy & Economics
2013 - 2016
Executive-in-Residence and Industry Advisor
2013 - 2016
Advised the healthcare and consumer group of leading private equity firm on prospective transactions and portfolio company investments
2012 - 2013
Senior Vice President, Global Corporate Affairs
2012 - 2013
Responsible for government affairs, public policy, patient advocacy, corporate communications, investor relations, and social media for this biopharmaceutical company prior to its acquisition by Amgen
2011 - 2012
Executive Vice President, General Counsel & Secretary
2011 - 2012
Innovative biotechnology company that developed and launched the first approved active cellular immunotherapy for the treatment of metastatic prostate cancer
2008 - 2011
Commissioner
2008 - 2011
Nominated by President George W. Bush and confirmed by the Senate to bipartisan presidential commission responsible for evaluating the effectiveness of our policies and programs in public diplomacy